Browse/search for people

Publication - Dr Charlotte Chamberlain

    The right amount of chemotherapy in non-curable disease

    insights from health economics

    Citation

    Hoch, JS, Beca, J, Chamberlain, C & Chan, KK, 2016, ‘The right amount of chemotherapy in non-curable disease: insights from health economics’. Journal of Cancer Policy, vol 10., pp. 30-35

    Abstract

    This article applies concepts from health economics to address what is the “right” amount of chemotherapy in non-curable disease. A health economics perspective is beneficial because it forces a focus on objectives and constraints. We review and apply the concepts of “Choice of Comparator”, “Use of QALYs” and “Equating Marginal Benefit to Marginal Cost”, demonstrating their fit for purpose when considering the optimal amount of chemotherapy for non-curable disease. Many efforts underway to improve healthcare can be viewed as applications of these key economic principles. The true value is in the concepts themselves and not in the associated calculations. Given the difference between a population and a patient perspective, different “optimal” amounts of chemotherapy may exist. For many, however, best may not be most. Optimal decisions may vary depending on whether the goal of treatment is to maximize hope or health.

    Full details in the University publications repository